Does the media prefer ITGR or IART?

In the previous week, Integra LifeSciences had 1 more articles in the media than Integer. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for Integer. Integra LifeSciences' average media sentiment score of 0.72 beat Integer's score of -0.27 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Integra LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SMA or IART?

In the previous week, Smartstop Self Storage REIT had 3 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for Smartstop Self Storage REIT and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 0.72 beat Smartstop Self Storage REIT's score of 0.13 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smartstop Self Storage REIT 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Integra LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IART or ATRC?

In the previous week, Integra LifeSciences had 1 more articles in the media than AtriCure. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for AtriCure. AtriCure's average media sentiment score of 0.93 beat Integra LifeSciences' score of 0.72 indicating that AtriCure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ATEC or IART?

In the previous week, Alphatec had 2 more articles in the media than Integra LifeSciences. MarketBeat recorded 5 mentions for Alphatec and 3 mentions for Integra LifeSciences. Alphatec's average media sentiment score of 1.22 beat Integra LifeSciences' score of 0.72 indicating that Alphatec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IART or ANGO?

In the previous week, Integra LifeSciences had 1 more articles in the media than AngioDynamics. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.16 beat Integra LifeSciences' score of 0.72 indicating that AngioDynamics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AngioDynamics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Integra LifeSciences (IART) Competitors

$15.61 -0.06 (-0.38%)

As of 12:27 PM Eastern

Compare

IART vs. ITGR, SMA, ATRC, ATEC, and ANGO

Should you buy Integra LifeSciences stock or one of its competitors? MarketBeat compares Integra LifeSciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integra LifeSciences include Integer (ITGR), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), Alphatec (ATEC), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

How does Integra LifeSciences compare to Integer?

Integer (NYSE:ITGR) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

In the previous week, Integra LifeSciences had 1 more articles in the media than Integer. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for Integer. Integra LifeSciences' average media sentiment score of 0.72 beat Integer's score of -0.27 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	1.66	$102.81M	$4.01	22.56
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$6.46	N/A

99.3% of Integer shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Integer presently has a consensus target price of $98.71, indicating a potential upside of 9.10%. Integra LifeSciences has a consensus target price of $14.00, indicating a potential downside of 10.31%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Integer has a net margin of 7.64% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	7.64%	12.83%	6.51%
Integra LifeSciences	-30.15%	17.42%	5.00%

Integer has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market.

Summary

Integer beats Integra LifeSciences on 11 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Smartstop Self Storage REIT (NYSE:SMA) and Integra LifeSciences (NASDAQ:IART) are both small-cap health care equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability.

In the previous week, Smartstop Self Storage REIT had 3 more articles in the media than Integra LifeSciences. MarketBeat recorded 6 mentions for Smartstop Self Storage REIT and 3 mentions for Integra LifeSciences. Integra LifeSciences' average media sentiment score of 0.72 beat Smartstop Self Storage REIT's score of 0.13 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smartstop Self Storage REIT	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Smartstop Self Storage REIT has higher earnings, but lower revenue than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smartstop Self Storage REIT	$294.00M	5.72	-$1.55M	$0.15	202.47
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$6.46	N/A

84.8% of Integra LifeSciences shares are owned by institutional investors. 5.5% of Smartstop Self Storage REIT shares are owned by insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Smartstop Self Storage REIT presently has a consensus target price of $37.17, indicating a potential upside of 22.38%. Integra LifeSciences has a consensus target price of $14.00, indicating a potential downside of 10.31%. Given Smartstop Self Storage REIT's stronger consensus rating and higher possible upside, analysts clearly believe Smartstop Self Storage REIT is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.73
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Smartstop Self Storage REIT has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

Smartstop Self Storage REIT has a net margin of 4.38% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Smartstop Self Storage REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smartstop Self Storage REIT	4.38%	1.00%	0.54%
Integra LifeSciences	-30.15%	17.42%	5.00%

Summary

Smartstop Self Storage REIT beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to AtriCure?

Integra LifeSciences (NASDAQ:IART) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

Integra LifeSciences presently has a consensus price target of $14.00, indicating a potential downside of 10.31%. AtriCure has a consensus price target of $48.71, indicating a potential upside of 88.89%. Given AtriCure's stronger consensus rating and higher probable upside, analysts plainly believe AtriCure is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
AtriCure	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.82

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by company insiders. Comparatively, 4.0% of AtriCure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AtriCure has a net margin of -0.83% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
AtriCure	-0.83%	0.29%	0.22%

Integra LifeSciences has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

In the previous week, Integra LifeSciences had 1 more articles in the media than AtriCure. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for AtriCure. AtriCure's average media sentiment score of 0.93 beat Integra LifeSciences' score of 0.72 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has lower revenue, but higher earnings than Integra LifeSciences. AtriCure is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$6.46	N/A
AtriCure	$552.16M	2.37	-$11.45M	-$0.10	N/A

Summary

AtriCure beats Integra LifeSciences on 12 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to Alphatec?

Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations.

In the previous week, Alphatec had 2 more articles in the media than Integra LifeSciences. MarketBeat recorded 5 mentions for Alphatec and 3 mentions for Integra LifeSciences. Alphatec's average media sentiment score of 1.22 beat Integra LifeSciences' score of 0.72 indicating that Alphatec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alphatec has higher earnings, but lower revenue than Integra LifeSciences. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$787.08M	1.47	-$143.36M	-$0.82	N/A
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$6.46	N/A

Alphatec currently has a consensus price target of $18.58, suggesting a potential upside of 147.78%. Integra LifeSciences has a consensus price target of $14.00, suggesting a potential downside of 10.31%. Given Alphatec's stronger consensus rating and higher probable upside, analysts plainly believe Alphatec is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67

Alphatec has a beta of 0.88, suggesting that its stock price is 12% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

66.3% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 13.5% of Alphatec shares are held by insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Alphatec has a net margin of -15.93% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-15.93%	-1,183.84%	-15.83%
Integra LifeSciences	-30.15%	17.42%	5.00%

Summary

Alphatec beats Integra LifeSciences on 10 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to AngioDynamics?

Integra LifeSciences (NASDAQ:IART) and AngioDynamics (NASDAQ:ANGO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, risk and analyst recommendations.

Integra LifeSciences has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

AngioDynamics has lower revenue, but higher earnings than Integra LifeSciences. AngioDynamics is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.74	-$516.47M	-$6.46	N/A
AngioDynamics	$313.73M	1.47	-$33.99M	-$0.75	N/A

AngioDynamics has a net margin of -10.01% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
AngioDynamics	-10.01%	-4.66%	-3.08%

Integra LifeSciences currently has a consensus target price of $14.00, suggesting a potential downside of 10.31%. AngioDynamics has a consensus target price of $18.67, suggesting a potential upside of 67.11%. Given AngioDynamics' stronger consensus rating and higher probable upside, analysts plainly believe AngioDynamics is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, Integra LifeSciences had 1 more articles in the media than AngioDynamics. MarketBeat recorded 3 mentions for Integra LifeSciences and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.16 beat Integra LifeSciences' score of 0.72 indicating that AngioDynamics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AngioDynamics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by company insiders. Comparatively, 6.0% of AngioDynamics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

AngioDynamics beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IART vs. The Competition

Export

Metric	Integra LifeSciences	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.21B	$6.99B	$6.26B	$12.44B
Dividend Yield	N/A	1.21%	2.69%	5.30%
P/E Ratio	-2.42	44.80	22.35	24.23
Price / Sales	0.74	85.66	555.60	126.08
Price / Cash	3.71	24.40	42.31	57.88
Price / Book	1.16	7.06	9.82	6.73
Net Income	-$516.47M	$159.22M	$3.56B	$336.97M
7 Day Performance	2.76%	0.37%	-1.16%	0.79%
1 Month Performance	42.56%	3.45%	3.85%	5.38%
1 Year Performance	19.71%	0.47%	27.33%	34.55%

Integra LifeSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IART Integra LifeSciences	1.129 of 5 stars	$15.61 -0.4%	$14.00 -10.3%	+27.2%	$1.21B	$1.64B	N/A	4,427
ITGR Integer	1.7218 of 5 stars	$89.71 +0.5%	$98.29 +9.6%	-23.4%	$3.05B	$1.85B	22.37	11,000
SMA Smartstop Self Storage REIT	4.2203 of 5 stars	$31.25 +0.9%	$36.94 +18.2%	-16.1%	$1.73B	$281.14M	208.33	N/A	Dividend Cut Analyst Forecast
ATRC AtriCure	3.6062 of 5 stars	$28.39 +0.4%	$48.71 +71.6%	-23.9%	$1.44B	$534.53M	N/A	1,300
ATEC Alphatec	3.7829 of 5 stars	$8.39 +1.5%	$18.58 +121.5%	-39.2%	$1.29B	$764.16M	N/A	700	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IART) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integra LifeSciences (IART) Competitors

IART vs. ITGR, SMA, ATRC, ATEC, and ANGO

How does Integra LifeSciences compare to Integer?

Summary

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Summary

How does Integra LifeSciences compare to AtriCure?

Summary

How does Integra LifeSciences compare to Alphatec?

Summary

How does Integra LifeSciences compare to AngioDynamics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integra LifeSciences (IART) Competitors

IART vs. ITGR, SMA, ATRC, ATEC, and ANGO

How does Integra LifeSciences compare to Integer?

Does the media prefer ITGR or IART?

Which has stronger earnings and valuation, ITGR or IART?

Do insiders & institutionals hold more shares of ITGR or IART?

Do analysts recommend ITGR or IART?

Is ITGR or IART more profitable?

Which has more risk & volatility, ITGR or IART?

Summary

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Does the media prefer SMA or IART?

Which has better earnings & valuation, SMA or IART?

Do insiders and institutionals believe in SMA or IART?

Do analysts rate SMA or IART?

Which has more risk & volatility, SMA or IART?

Is SMA or IART more profitable?

Summary

How does Integra LifeSciences compare to AtriCure?

Do analysts rate IART or ATRC?

Do insiders & institutionals believe in IART or ATRC?

Is IART or ATRC more profitable?

Which has more risk and volatility, IART or ATRC?

Does the media favor IART or ATRC?

Which has stronger earnings & valuation, IART or ATRC?

Summary

How does Integra LifeSciences compare to Alphatec?

Does the media refer more to ATEC or IART?

Which has higher earnings & valuation, ATEC or IART?

Do analysts rate ATEC or IART?

Which has more risk & volatility, ATEC or IART?

Do insiders and institutionals have more ownership in ATEC or IART?

Is ATEC or IART more profitable?

Summary

How does Integra LifeSciences compare to AngioDynamics?

Which has more volatility and risk, IART or ANGO?

Which has higher valuation and earnings, IART or ANGO?

Is IART or ANGO more profitable?

Do analysts prefer IART or ANGO?

Does the media favor IART or ANGO?

Do insiders & institutionals have more ownership in IART or ANGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools